Effect of reducing the number of neoadjuvant chemoimmunotherapy cycles on clinical efficacy in locally advanced PD-L1 positive gastric cancer: A single center phase 2 study.
Lingdi Zhao(Zhengzhou University), Quanli Gao(Zhengzhou University), Bin Zhang(Capital Medical University), Jialin Liu(Shanghai Jiao Tong University), Zhi Li(Central South University), Zhiqiang Jiang, Jinxi Huang(Zhengzhou University), Qiang Fu(Monash University), Zhimeng Li(Zhengzhou University), Xiangbin Wan(Zhengzhou University), Ye Kong, Yuzhou Zhao(Capital Medical University), Yingkun Ren(Zhengzhou University), Chuang Shang(Zhengzhou University)
Cited by 1
Related Papers
IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
|Nature Immunology|2021|374
Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells
|Journal of Experimental & Clinical Cancer Research|2019|324
Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis
|Stroke|2015|279
The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer—A Phase II Study
|Frontiers in Immunology|2021|73
Cancer-associated fibroblasts promote the migration and invasion of gastric cancer cells via activating IL-17a/JAK2/STAT3 signaling
|Annals of Translational Medicine|2020|71